Genomics Personalized Health Market: Segmented: By Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Others), By Technology (NGS Platforms, RT-PCR, Microarray, Genetic Analyzers), By End User (Academic Research Institutes, Diagnostic Centers, Others), And Region – Global Analysis Of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
According to a recently published Fatpos Global study on "Genomics Personalized Health Market," the market is segmented by material type, thickness, application, transparency, end-use industry, and geography.
The Genomics Personalized Health Market grew from USD 8.59 Billion in 2022 to USD 31.46 Billion by 3032, exhibiting a CAGR of 12.5% during the forecast period.
In addition, the study includes supply and demand risk, market attractiveness, BPS analysis, and Porter's five force model for an in-depth examination of the industry's growth drivers and inhibitors.
This research offers company profiles of some of the major competitors in the worldwide Genomics Personalized Health Market market as well as information on their current competitive environment.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Vikor Scientific
- Roche Holding AG
- Qiagen
- Quantgene
- Bio-Rad Laboratories Inc.
- Lonza Group AG
- ARCA biopharma
- Invitae Corporation
- Genetic Technologies Limited
- Interleukin Genetics Inc.
- Eastern Biotech and Life Sciences
- DNA Genotek Inc.
- XCode Life Sciences Private Limited.
- Other Prominent Players
COVID-19 Impact on Genomics Personalized Health Market
Throughout the COVID-19 epidemic, we are working nonstop to support and expand your business. We will provide you with a coronavirus impact study across industries based on our experience and knowledge to assist you in getting ready for the future.
Many industries, markets, and enterprises are under a great deal of stress as a result of the COVID-19 outbreak, which has caused significant economic suffering and uncertainty. However, by working together, the entire world can overcome these difficult times. At Fatpos Global, we strive to deliver exact market intelligence by doing in-depth research into how this pandemic will affect various industries.
We're working hard to support your company's growth and survival amid the COVID-19 epidemic. We will provide you with a coronavirus impact study across industries based on our experience and knowledge to assist you in getting ready for the future.
Market segment by Region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Genomics Personalized Health Market Segments
- By Test Type
- Oncology Testing
- Infectious Disease Testing
- Orphan Disease Testing
- Autoimmune Disease Testing
- Obstetrics Testing
- Others
- By Technology
- NGS Platforms
- RT-PCR
- Microarray
- Genetic Analyzers
- By End User
- Academic Research Institutes
- Diagnostic Centers
- Other
The Genomics Personalized Health Market report provides answers to the following key questions:
- What are the key outcomes of the five forces analysis of the global?
- Which are Trending factors influencing the market shares of the top regions across the globe?
- What is the impact of Covid19 on the current industry?
- What are the market opportunities and threats faced by Genomics Personalized Health Market?
- 1 Executive Summary
- 2 Global Genomics Personalized Health Market
- 2.1. Product Overview
- 2.2. Market Definition
- 2.3. Segmentation
- 2.4. Assumptions and Acronyms
- 3 Research Methodology
- 3.1. Research Objectives
- 3.2. Primary Research
- 3.3. Secondary Research
- 3.4. Forecast Model
- 3.5. Market Size Estimation
- 4 Average Pricing Analysis
- 5 Macro-Economic Indicators
- 6 Market Dynamics
- 6.1. Growth Drivers
- 6.2. Restraints
- 6.3. Opportunity
- 6.4. Trends
- 7 Correlation & Regression Analysis
- 7.1. Correlation Matrix
- 7.2. Regression Matrix
- 8 Recent Development, Policies & Regulatory Landscape
- 9 Risk Analysis
- 9.1. Demand Risk Analysis
- 9.2. Supply Risk Analysis
- 10 Global Genomics Personalized Health Market Analysis
- 10.1. Porters Five Forces
- 10.1.1. Threat of New Entrants
- 10.1.2. Bargaining Power of Suppliers
- 10.1.3. Threat of Substitutes
- 10.1.4. Rivalry
- 10.2. PEST Analysis
- 10.2.1. Political
- 10.2.2. Economic
- 10.2.3. Social
- 10.2.4. Technological
- 11 Global Genomics Personalized Health Market
- 11.1. Market Size & forecast, 2020A-2030F
- 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12 Global Oncology Pharmaceuticals Market: Market Segmentation
- 12.1. By Regions
- 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2. By Type: Market Share (2020-2030F)
- 12.2.1. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.2. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.4. Hormonal Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3. By Indication: Market Share (2020-2030F)
- 12.3.1. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.2. Stomach Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.3. Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.4. Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.4. By End user: Market Share (2020-2030F)
- 12.4.1. Specialized cancer treatment centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.4.2. Hospitals Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 13 Company Profile
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Vikor Scientific
- Roche Holding AG
- Qiagen
- Quantgene
- Bio-Rad Laboratories Inc.
- Lonza Group AG
- ARCA biopharma
- Invitae Corporation
- Genetic Technologies Limited
- Interleukin Genetics Inc.
- Eastern Biotech and Life Sciences
- DNA Genotek Inc.
- XCode Life Sciences Private Limited.
- Other Prominent Players
- 14 Consultant Recommendation
- **The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook